About LRRK 2 Cohort Consortium
The LRRK2 Cohort Consortium, funded by the Michael J. Fox Foundation, brought research groups together to speed efforts to move LRRK2 toward therapeutic relevance for patients. The CTSDMC served as the Statistical Core for this project.
LRRK2 Cohort Consortium IS A COMPLETED STUDY
For more information and to view the results of this study, please visit the study website.